Financhill
Back

MoonLake Immunotherapeutics Quote, Financials, Valuation and Earnings

MoonLake Immunotherapeutics Price Quote

$43.24
+0.42 (+0.98%)
(Updated: May 2, 2024 at 1:25 PM ET)

MoonLake Immunotherapeutics Key Stats

Buy
54
MoonLake Immunotherapeutics (MLTX) is a Buy

Day range:
$41.11 - $43.65
52-week range:
$20.35 - $64.98
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.43%

Volume:
338.6K
Avg. volume:
394K
1-year change:
88.63%
Market cap:
$2.7B
Revenue:
$0
EPS:
$-0.74

How Much Does MoonLake Immunotherapeutics Make?

Data Unavailable

Is MoonLake Immunotherapeutics Growing As A Company?

Data Unavailable

MoonLake Immunotherapeutics Stock Price Performance

What Is MoonLake Immunotherapeutics 52-Week High & Low?

MoonLake Immunotherapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy MoonLake Immunotherapeutics?

Is MoonLake Immunotherapeutics Cash Flow Positive?

  • What Is MLTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$42.8M
  • What Is MoonLake Immunotherapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $479.7M
  • What Is MoonLake Immunotherapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$25.2M

MoonLake Immunotherapeutics Return On Invested Capital

Data Unavailable

MoonLake Immunotherapeutics Earnings Date & Stock Price

MoonLake Immunotherapeutics Competitors

MoonLake Immunotherapeutics Dividend Yield

Data Unavailable

MoonLake Immunotherapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 54.73%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 73.38
Upside from Last Price: 71.38%

Major Shareholders

  • How many MLTX shares are owned by institutional investors?
    68.6M MLTX shares are owned by institutional investors
  • How many MLTX shares are owned by insiders?
    3.5M MLTX shares are owned by insiders